adenine has been researched along with Secondary Hyperparathyroidism in 8 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Here, we established a rat model with secondary hyperparathyroidism (SHPT) and bone disease induced by adenine and a high phosphorous diet and analyzed the skeletal characteristics." | 3.88 | A rat model of SHPT with bone abnormalities in CKD induced by adenine and a high phosphorus diet. ( Chen, Q; Liu, BC; Lv, LL; Ni, HF; Ni, LH; Song, KY; Tang, RN; Wang, B; Wang, FM; Wang, LT; Wu, M, 2018) |
| "After adenine dosing, significant hyperphosphatemia, hypocalcemia and secondary hyperparathyroidism (2HPT) were observed during the experimental period of 15 weeks." | 3.75 | Vascular calcification and secondary hyperparathyroidism of severe chronic kidney disease and its relation to serum phosphate and calcium levels. ( Fujimori, A; Fukushima, S; Itoh, H; Mizukami, K; Nara, H; Okada, M; Sanagi, M; Takakura, K; Terai, K, 2009) |
| "Tenofovir disoproxil fumarate is the first-line antiviral therapy for chronic viral hepatitis B, but long-term use is associated with renal failure and hypophosphatemic osteomalacia." | 2.82 | Tenofovir-induced osteopenia and hyperparathyroidism: A case report and literature review. ( Li, L; Ma, W; Wei, D; Ye, P; Zeng, J, 2022) |
| "Secondary hyperparathyroidism is characterized by increased parathyroid hormone (PTH) mRNA stability that leads to increased PTH mRNA and serum PTH levels." | 1.35 | Regulation of PTH mRNA stability by the calcimimetic R568 and the phosphorus binder lanthanum carbonate in CKD. ( Ben-Dov, IZ; Naveh-Many, T; Nechama, M; Silver, J, 2009) |
| "At week 9, renal failure resolved with improvement in the hyperparathyroid state." | 1.35 | Uraemic hyperparathyroidism causes a reversible inflammatory process of aortic valve calcification in rats. ( Abedat, S; Beeri, R; Ben-Dov, IZ; Danenberg, HD; Lotan, C; Meir, K; Planer, D; Shuvy, M; Sosna, J, 2008) |
| "Adenine-treated rats showed marked elevations of serum phosphorus, PTH and FGF23 levels associated with parathyroid hyperplasia and aortic calcification." | 1.33 | [Effects of intermittent treatment with sevelamer hydrochloride on parathyroid hyperplasia and vascular calcification in rats with chronic kidney disease]. ( Abe, M; Kobayashi, N; Miyata, S; Nagano, N; Wada, M; Wakita, S, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sato, H | 3 |
| Goto, M | 3 |
| Nishimura, G | 3 |
| Morimoto, N | 3 |
| Tokushima, H | 3 |
| Horii, Y | 3 |
| Takahashi, N | 3 |
| Zeng, J | 1 |
| Ye, P | 1 |
| Wei, D | 1 |
| Li, L | 1 |
| Ma, W | 1 |
| Ni, LH | 1 |
| Tang, RN | 1 |
| Lv, LL | 1 |
| Wu, M | 1 |
| Wang, B | 1 |
| Wang, FM | 1 |
| Ni, HF | 1 |
| Song, KY | 1 |
| Wang, LT | 1 |
| Chen, Q | 1 |
| Liu, BC | 1 |
| Nechama, M | 1 |
| Ben-Dov, IZ | 3 |
| Silver, J | 2 |
| Naveh-Many, T | 2 |
| Terai, K | 1 |
| Nara, H | 1 |
| Takakura, K | 1 |
| Mizukami, K | 1 |
| Sanagi, M | 1 |
| Fukushima, S | 1 |
| Fujimori, A | 1 |
| Itoh, H | 1 |
| Okada, M | 1 |
| Galitzer, H | 1 |
| Nagano, N | 1 |
| Miyata, S | 1 |
| Abe, M | 1 |
| Wakita, S | 1 |
| Kobayashi, N | 1 |
| Wada, M | 1 |
| Shuvy, M | 1 |
| Abedat, S | 1 |
| Beeri, R | 1 |
| Danenberg, HD | 1 |
| Planer, D | 1 |
| Meir, K | 1 |
| Sosna, J | 1 |
| Lotan, C | 1 |
1 review available for adenine and Secondary Hyperparathyroidism
| Article | Year |
|---|---|
Tenofovir-induced osteopenia and hyperparathyroidism: A case report and literature review.
Topics: Adenine; Bone Diseases, Metabolic; Calcium; Humans; Hyperparathyroidism, Primary; Hyperparathyroidis | 2022 |
7 other studies available for adenine and Secondary Hyperparathyroidism